Jan 29, 2026 · 44 min
Cramer tests AI, apparel and pharma stocks against scarcity
Mad Money w/ Jim Cramer 1/28/26
The episode uses one investing question—shortage or glut—to compare AI disruption, brand expansion and a pharmaceutical turnaround.
- 1ServiceNow argues that generative AI can strengthen enterprise software rather than replace it.
- 2Levi Strauss is pursuing growth through direct sales, international expansion and a broader women’s business.
- 3Teva is positioning neurology and other innovative medicines as a break from its generic-drug legacy.
Don't miss
Richard Francis explains how Teva’s neurology and specialty-medicine pipeline is intended to transform its generic-drug identity.
The brief
Jim Cramer opens with a simple earnings-season test: decide whether a company faces a shortage or a glut, then applies it to viewer stock questions.
ServiceNow CEO Bill McDermott addresses the central software fear—that generative AI will replace enterprise platforms—while discussing partnerships, growth, pricing and capital returns.
Levi Strauss CEO Michelle Gass makes the case for a business expanding beyond denim through direct-to-consumer sales, e-commerce, international growth and its women’s category.
Teva CEO Richard Francis describes a company moving beyond its generic-drug reputation, with neurology, migraine and schizophrenia treatments supporting an innovative biopharma strategy.
The lightning round returns to individual stocks, including Robinhood, Satellogic and Energy Transfer, as Cramer weighs speculation, dividends and AI pressure on software.
What was said on this episode
42 statements · 34 positive · 7 negative · 1 mixed
Gold miners increase global gold supply by only 1% annually.
“The miners only grow the supply by 1%.”
Listen at 1:56
Cramer favors Agnico Eagle among gold miners.
“I like Agnico Eagle.”
Listen at 2:04
Cramer recommends holding gold.
“I would keep the gold.”
Listen at 2:39
Cramer recommends selling silver.
“Sell, sell, sell.”
Listen at 2:58
NVIDIA’s high-end chips give Micron substantial pricing power.
“In this situation where you have NVIDIA's new high-end chips spewing data, Micron has absurd pricing power.”
Listen at 3:40
The memory and data-storage shortage will persist for some time.
“I think the shortage lasts for some time.”
Listen at 4:04
Western Digital and SanDisk shares will continue rising.
“I expect these stocks to continue ramping”
Listen at 4:27
The United States currently faces a power shortage.
“We're a nation short on power, too.”
Listen at 5:05
Gas turbines have become one of the world’s biggest growth stories.
“It's now one of the biggest growth stories in the world.”
Listen at 5:30
GE Vernova cannot fully satisfy customer demand.
“So GE Vinova, the GE Power spinoff, can't come nearly satisfying their clients.”
Listen at 5:33
Cramer views IBM as well managed and inexpensive.
“I think IBM is incredibly well run by Arvind Krishna and is an inexpensive stock even here.”
Listen at 7:36
Companies producing scarce goods are currently the stock market’s best performers.
“The best performers in the entire stock market, not tech, the entire stock market, are companies that you may never have heard of. They make things that are in short supply and their stocks keep soaring.”
Listen at 7:48
Buying Texas Pacific Land is speculative and depends on higher oil prices.
“I think you can do it on a spec, but you're going to be betting, by the way, that oil is going to go higher.”
Listen at 8:57
Cramer recommends buying Netflix.
“I think that you got to pull the trigger on Netflix.”
Listen at 9:22
ServiceNow exceeds 20% revenue growth and 35% free-cash-flow margin.
“we're growing revenue more than 20 percent and free cash flow margin more than 35.”
Listen at 13:05
ServiceNow operates in an agentic-AI market where companies want platforms.
“we're in an agentic AI universe and companies today want a platform.”
Listen at 13:16
ServiceNow’s platform complements language models and leads business-process reinvention.
“we're harmonious with the language models. It's synchronous with business process reinvention. And we're leading the way.”
Listen at 14:51
AI will displace some feature and functional software companies.
“I see feature companies and perhaps some functional companies actually being eaten by AI”
Listen at 15:01
ServiceNow monthly active users increased 25% year over year.
“We're actually increasing the monthly active users at ServiceNow 25%. year over year.”
Listen at 16:01
ServiceNow’s total addressable market grew from $90 billion to $600 billion since 2019.
“our TAM went from 90 to 600 billion since 2019”
Listen at 18:59
Cybercrime is forecast to cost the world $1 trillion monthly.
“cybercrime is forecast to cost the world $1 trillion a month.”
Listen at 19:45
Levi Strauss direct-to-consumer sales increased 10%.
“DTC was up 10 percent.”
Listen at 22:24
Direct-to-consumer sales now represent half of Levi Strauss’s business.
“It's now half of our business.”
Listen at 22:37
Levi Strauss will advertise during the Super Bowl for the first time in 20 years.
“we are going to have an ad on the Super Bowl the first time in 20 years.”
Listen at 23:46
Levi Strauss expects 4–5% underlying growth and 5–6% reported growth next year.
“We looked at 4% to 5% next year, 5% to 6% reported, and expanding margin at the same time.”
Listen at 25:50
Levi Strauss tops delivered double-digit growth in the quarter.
“our tops. It's been double digit growth, you know, again, this quarter.”
Listen at 26:21
Levi Strauss sees substantial growth opportunity across Asia.
“throughout Asia, Asia, we see a ton of runway for us.”
Listen at 27:07
Levi Strauss women’s business grew 11% and could rise from 38% to 50% of sales.
“Women's was up 11% for the year, and we have a long way to go between 38% and 50%”
Listen at 27:49
Teva has developed treatments targeting schizophrenia, migraine, and tardive dyskinesia.
“we're very proud that we've taken on schizophrenia, we've taken on migraine, we've taken on tardive dyskinesia.”
Listen at 30:36
Teva expects Austedo peak sales of $3 billion.
“we have peak sales of 3 billion.”
Listen at 31:08
Eighty-five percent of relevant patients remain untreated.
“85% of patients are still not on treatment.”
Listen at 31:15
Teva’s treatment can substantially improve patients’ quality of life.
“it can really transform the quality of life.”
Listen at 31:37
Teva’s migraine product grew 30% in 2025 and is forecast to grow substantially next year.
“In 2025, it was up 30%. And now we've given a forecast next year that has tremendous growth in it.”
Listen at 32:01
Teva’s UZEDY grew 63% last year.
“that was up 63 percent last year.”
Listen at 33:20
Teva’s long-acting olanzapine could transform schizophrenia treatment.
“when we launch... LAI, our long-acting olanzapine, I think we have a real opportunity to transform the treatment for those patients.”
Listen at 33:50
Teva expects to launch four products within five years.
“we're going to have an opportunity to launch. four products in five years.”
Listen at 34:43
Teva expects seven innovative milestones in 2026.
“we have seven milestones this year, and they're all innovative.”
Listen at 34:55
Teva’s scientific capabilities have been substantially underestimated.
“the quality of science we have at Teva, I think, has been way underestimated.”
Listen at 35:34
Robinhood has attracted a young customer cohort.
“Robin Hood has captured that young cohort.”
Listen at 37:18
Satellogic is rising parabolically ahead of a major earnings increase.
“this thing is a parabolic move. When I see a parabolic move for a company that's about to have a big earnings step up, I say I got to call Ben Stoto because I am not going to say that this five dollar stock. shouldn't be for you.”
Listen at 37:38
Energy Transfer offers a 7.3% yield and is inexpensive.
“The Yield 7.3, very inexpensive stock. Great pipeline company.”
Listen at 38:35
Cramer recommends buying enterprise software stocks.
“So I think it should do better. So I agree with you. I'll be a buyer.”
Listen at 39:18
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Weekly email
State of the Pod, every Monday
The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.